BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35186188)

  • 1. miR-488-3p Protects Cardiomyocytes against Doxorubicin-Induced Cardiotoxicity by Inhibiting CyclinG1.
    Yan M; Cao Y; Wang Q; Xu K; Dou L; Huang X; Chen B; Tang W; Lan M; Liu B; Zhu K; Yang Y; Sun S; Zhang X; Man Y; Hei M; Shen T; Li J
    Oxid Med Cell Longev; 2022; 2022():5184135. PubMed ID: 35186188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity.
    Liu Y; Duan C; Liu W; Chen X; Wang Y; Liu X; Yue J; Yang J; Zhou X
    Arch Toxicol; 2019 Nov; 93(11):3261-3276. PubMed ID: 31570982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p.
    Yu X; Ruan Y; Shen T; Qiu Q; Yan M; Sun S; Dou L; Huang X; Wang Q; Zhang X; Man Y; Tang W; Jin Z; Li J
    Biomed Res Int; 2020; 2020():5107193. PubMed ID: 32190669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-24-3p Attenuates Doxorubicin-induced Cardiotoxicity via the Nrf2 Pathway in Mice.
    Fan D; Chen HB; Leng Y; Yang SJ
    Curr Med Sci; 2022 Feb; 42(1):48-55. PubMed ID: 35089495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
    Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
    Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a.
    Han D; Wang Y; Wang Y; Dai X; Zhou T; Chen J; Tao B; Zhang J; Cao F
    Circ Res; 2020 Jul; 127(4):e108-e125. PubMed ID: 32392088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA PVT1 aggravates doxorubicin-induced cardiomyocyte apoptosis by targeting the miR-187-3p/AGO1 axis.
    Zhan J; Hu P; Wang Y
    Mol Cell Probes; 2020 Feb; 49():101490. PubMed ID: 31786333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal LncRNA-NEAT1 derived from MIF-treated mesenchymal stem cells protected against doxorubicin-induced cardiac senescence through sponging miR-221-3p.
    Zhuang L; Xia W; Chen D; Ye Y; Hu T; Li S; Hou M
    J Nanobiotechnology; 2020 Oct; 18(1):157. PubMed ID: 33129330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA therapy confers anti-senescent effects on doxorubicin-related cardiotoxicity by intracellular and paracrine signaling.
    Xia W; Chang B; Li L; Hu T; Ye J; Chen H; Li W; Zan T; Hou M
    Aging (Albany NY); 2021 Dec; 13(23):25256-25270. PubMed ID: 34864645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rutin protects against pirarubicin-induced cardiotoxicity by adjusting microRNA-125b-1-3p-mediated JunD signaling pathway.
    Li Q; Qin M; Li T; Gu Z; Tan Q; Huang P; Ren L
    Mol Cell Biochem; 2020 Mar; 466(1-2):139-148. PubMed ID: 32016695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-129-1-3p protects cardiomyocytes from pirarubicin-induced apoptosis by down-regulating the GRIN2D-mediated Ca
    Li Q; Qin M; Tan Q; Li T; Gu Z; Huang P; Ren L
    J Cell Mol Med; 2020 Feb; 24(3):2260-2271. PubMed ID: 31957170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA miR-215-5p Regulates Doxorubicin-induced Cardiomyocyte Injury by Targeting ZEB2.
    Xiong X; He Q; Liu J; Dai R; Zhang H; Cao Z; Liao Y; Liu B; Zhou Y; Chen J; Chen M; Liu J
    J Cardiovasc Pharmacol; 2021 Oct; 78(4):622-629. PubMed ID: 34282068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-148b-3p is involved in regulating hypoxia/reoxygenation-induced injury of cardiomyocytes in vitro through modulating SIRT7/p53 signaling.
    Sun M; Zhai M; Zhang N; Wang R; Liang H; Han Q; Jia Y; Jiao L
    Chem Biol Interact; 2018 Dec; 296():211-219. PubMed ID: 30308185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity.
    Jing X; Yang J; Jiang L; Chen J; Wang H
    Cell Physiol Biochem; 2018; 48(2):692-704. PubMed ID: 30025410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs as potential biomarkers for doxorubicin-induced cardiotoxicity.
    Holmgren G; Synnergren J; Andersson CX; Lindahl A; Sartipy P
    Toxicol In Vitro; 2016 Aug; 34():26-34. PubMed ID: 27033315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway.
    Du J; Hang P; Pan Y; Feng B; Zheng Y; Chen T; Zhao L; Du Z
    Toxicol Appl Pharmacol; 2019 Apr; 369():73-81. PubMed ID: 30831132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irigenin treatment alleviates doxorubicin (DOX)-induced cardiotoxicity by suppressing apoptosis, inflammation and oxidative stress via the increase of miR-425.
    Guo L; Zheng X; Wang E; Jia X; Wang G; Wen J
    Biomed Pharmacother; 2020 May; 125():109784. PubMed ID: 32092815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.
    Chaudhari U; Nemade H; Gaspar JA; Hescheler J; Hengstler JG; Sachinidis A
    Arch Toxicol; 2016 Dec; 90(12):3087-3098. PubMed ID: 26842497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA-30e mediated cardioprotection of ACE2 in rats with Doxorubicin-induced heart failure through inhibiting cardiomyocytes autophagy.
    Lai L; Chen J; Wang N; Zhu G; Duan X; Ling F
    Life Sci; 2017 Jan; 169():69-75. PubMed ID: 27633839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1.
    Zhao X; Jin Y; Li L; Xu L; Tang Z; Qi Y; Yin L; Peng J
    Pharmacol Res; 2019 Aug; 146():104276. PubMed ID: 31112750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.